{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:10:27Z","timestamp":1790676627283,"version":"4.1.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11926-016-0568-x","type":"journal-article","created":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T00:38:35Z","timestamp":1456706315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome"],"prefix":"10.1007","volume":"18","author":[{"given":"C\u00e9cile M.","family":"Yelnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Kozora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Appenzeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,29]]},"reference":[{"issue":"8361","key":"568_CR1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(83)91267-9","volume":"2","author":"EN Harris","year":"1983","unstructured":"Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet Lond Engl. 1983;2(8361):1211\u20134.","journal-title":"Lancet Lond Engl"},{"issue":"7","key":"568_CR2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42(7):1309\u201311.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"568_CR3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost JTH. 2006;4(2):295\u2013306.","journal-title":"J Thromb Haemost JTH"},{"issue":"9","key":"568_CR4","first-page":"1725","volume":"24","author":"M Kent","year":"1997","unstructured":"Kent M, Alvarez F, Vogt E, Fyffe R, Ng AK, Rote N. Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system. J Rheumatol. 1997;24(9):1725\u201333.","journal-title":"J Rheumatol"},{"issue":"2","key":"568_CR5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-510X(98)00027-6","volume":"156","author":"B Caronti","year":"1998","unstructured":"Caronti B, Pittoni V, Palladini G, Valesini G. Anti-beta 2-glycoprotein I antibodies bind to central nervous system. J Neurol Sci. 1998;156(2):211\u20139.","journal-title":"J Neurol Sci"},{"issue":"6","key":"568_CR6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1191\/0961203303lu409oa","volume":"12","author":"Y Shoenfeld","year":"2003","unstructured":"Shoenfeld Y, Nahum A, Korczyn AD, Dano M, Rabinowitz R, Beilin O, et al. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus. 2003;12(6):436\u201342.","journal-title":"Lupus"},{"issue":"5","key":"568_CR7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.autrev.2015.01.002","volume":"14","author":"MM Abreu","year":"2015","unstructured":"Abreu MM, Danowski A, Wahl DG, Amigo M-C, Tektonidou M, Pacheco MS, et al. The relevance of \u201cnon-criteria\u201d clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features. Autoimmun Rev. 2015;14(5):401\u201314. Last report of international experts\u2019 conference, which summarizes experts\u2019 conclusions on clinical non-criteria manifestations of APS and their place in the classification criteria.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"568_CR8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1076\/jcen.21.2.251.931","volume":"21","author":"MW Jacobson","year":"1999","unstructured":"Jacobson MW, Rapport LJ, Keenan PA, Coleman RD, Tietjen GE. Neuropsychological deficits associated with antiphospholipid antibodies. J Clin Exp Neuropsychol. 1999;21(2):251\u201364.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"5","key":"568_CR9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/0961203309355300","volume":"19","author":"D Erkan","year":"2010","unstructured":"Erkan D, Barbhaiya M, George D, Sammaritano L, Lockshin M. Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information? Lupus. 2010;19(5):613\u20139.","journal-title":"Lupus"},{"issue":"1","key":"568_CR10","first-page":"34","volume":"32","author":"E Kozora","year":"2014","unstructured":"Kozora E, Erkan D, Zhang L, Zimmerman R, Ramon G, Ulug AM, et al. Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients. Clin Exp Rheumatol. 2014;32(1):34\u201340. Proof of aPL implication in cognitive dysfunction independently of overlap with lupus.","journal-title":"Clin Exp Rheumatol"},{"issue":"20","key":"568_CR11","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1001\/archinte.166.20.2278","volume":"166","author":"MG Tektonidou","year":"2006","unstructured":"Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med. 2006;166(20):2278\u201384.","journal-title":"Arch Intern Med"},{"issue":"8","key":"568_CR12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/0961203315572717","volume":"24","author":"MA Co\u00edn","year":"2015","unstructured":"Co\u00edn MA, Vilar-L\u00f3pez R, Peralta-Ram\u00edrez I, Hidalgo-Ruzzante N, Callejas-Rubio JL, Ortego-Centeno N, et al. The role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupus erythematosus. Lupus. 2015;24(8):875\u20139. Recent paper with good methodology to evaluate the association between aPL and cognitive dysfunction.","journal-title":"Lupus"},{"key":"568_CR13","doi-asserted-by":"crossref","unstructured":"Krause I, Lev S, Fraser A, Blank M, Lorber M, Stojanovich L, et al. Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome. Ann Rheum Dis. 2005;64(10):1490\u20133.","DOI":"10.1136\/ard.2004.032813"},{"issue":"4","key":"568_CR14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.md.0000172074.53583.ea","volume":"84","author":"JA G\u00f3mez-Puerta","year":"2005","unstructured":"G\u00f3mez-Puerta JA, Mart\u00edn H, Amigo M-C, Aguirre MA, Camps MT, Cuadrado MJ, et al. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine (Baltimore). 2005;84(4):225\u201330.","journal-title":"Medicine (Baltimore)"},{"key":"568_CR15","first-page":"981519","volume":"2012","author":"JF Carvalho De","year":"2012","unstructured":"De Carvalho JF, Pasoto SG, Appenzeller S. Seizures in primary antiphospholipid syndrome: the relevance of smoking to stroke. Clin Dev Immunol. 2012;2012:981519.","journal-title":"Clin Dev Immunol"},{"key":"568_CR16","doi-asserted-by":"crossref","unstructured":"Krause I, Blank M, Fraser A, Lorber M, Stojanovich L, Rovensky J, et al. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. Immunobiology. 2005;210(10):749\u201354.","DOI":"10.1016\/j.imbio.2005.10.005"},{"key":"568_CR17","unstructured":"Etemadifar M, Dehghani L, Tahani S, Toghianifar N, Rahaimi M, Eskandari N. Neurological manifestations in patients with antiphospholipid syndrome. Iran J Neurol. 2013;12(4):172\u20135."},{"issue":"9","key":"568_CR18","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1007\/s00296-011-2120-7","volume":"32","author":"S Appenzeller","year":"2012","unstructured":"Appenzeller S, Yeh S, Maruyama M, Barros SM, de Carvalho JF. Chorea in primary antiphospholipid syndrome is associated with rheumatic fever. Rheumatol Int. 2012;32(9):2857\u201361.","journal-title":"Rheumatol Int"},{"issue":"4","key":"568_CR19","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette J-C, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019\u201327.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"568_CR20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10067-002-8287-2","volume":"21","author":"Y Sherer","year":"2002","unstructured":"Sherer Y, Hassin S, Shoenfeld Y, Levy Y, Livneh A, Ohry A, et al. Transverse myelitis in patients with antiphospholipid antibodies\u2014the importance of early diagnosis and treatment. Clin Rheumatol. 2002;21(3):207\u201310.","journal-title":"Clin Rheumatol"},{"issue":"203\u2013204","key":"568_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-510X(02)00271-X","volume":"15","author":"J Chapman","year":"2002","unstructured":"Chapman J, Abu-Katash M, Inzelberg R, Yust I, Neufeld MY, Vardinon N, et al. Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants. J Neurol Sci. 2002;15(203\u2013204):81\u20134.","journal-title":"J Neurol Sci"},{"issue":"4","key":"568_CR22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S1355617797003779","volume":"3","author":"SD Denburg","year":"1997","unstructured":"Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc JINS. 1997;3(4):377\u201386.","journal-title":"J Int Neuropsychol Soc JINS"},{"issue":"4","key":"568_CR23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1076\/jcen.24.4.527.1038","volume":"24","author":"E Leritz","year":"2002","unstructured":"Leritz E, Brandt J, Minor M, Reis-Jensen F, Petri M. Neuropsychological functioning and its relationship to antiphospholipid antibodies in patients with systemic lupus erythematosus. J Clin Exp Neuropsychol. 2002;24(4):527\u201333.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"4","key":"568_CR24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L","volume":"42","author":"S Menon","year":"1999","unstructured":"Menon S, Jameson-Shortall E, Newman SP, Hall-Craggs MR, Chinn R, Isenberg DA. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum. 1999;42(4):735\u201341.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"568_CR25","doi-asserted-by":"crossref","first-page":"e33824","DOI":"10.1371\/journal.pone.0033824","volume":"7","author":"F Conti","year":"2012","unstructured":"Conti F, Alessandri C, Perricone C, Scrivo R, Rezai S, Ceccarelli F, et al. Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage. PLoS ONE. 2012;7(3):e33824.","journal-title":"PLoS ONE"},{"issue":"6","key":"568_CR26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/096120339500400611","volume":"4","author":"A Juby","year":"1995","unstructured":"Juby A, Davis P, Genge T, McElhaney J. Anticardiolipin antibodies in two elderly subpopulations. Lupus. 1995;4(6):482\u20135.","journal-title":"Lupus"},{"issue":"1","key":"568_CR27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000017211","volume":"11","author":"A Mosek","year":"2000","unstructured":"Mosek A, Yust I, Treves TA, Vardinon N, Korczyn AD, Chapman J. Dementia and antiphospholipid antibodies. Dement Geriatr Cogn Disord. 2000;11(1):36\u20138.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"928","key":"568_CR28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/pmj.79.928.81","volume":"79","author":"GRV Hughes","year":"2003","unstructured":"Hughes GRV. Migraine, memory loss, and \u201cmultiple sclerosis\u201d. Neurological features of the antiphospholipid (Hughes\u2019) syndrome. Postgrad Med J. 2003;79(928):81\u20133.","journal-title":"Postgrad Med J"},{"issue":"10","key":"568_CR29","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1526-4610.1991.hed3110666.x","volume":"31","author":"C I\u00f1iguez","year":"1991","unstructured":"I\u00f1iguez C, Pascual C, Pardo A, Martinez-Castrillo JC, Alvarez-Cerme\u00f1o JC. Antiphospholipid antibodies in migraine. Headache. 1991;31(10):666\u20138.","journal-title":"Headache"},{"issue":"7","key":"568_CR30","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1538-7836.2011.04348.x","volume":"9","author":"C Cavestro","year":"2011","unstructured":"Cavestro C, Micca G, Molinari F, Bazzan M, DI Pietrantonj C, Aloi R, et al. Migraineurs show a high prevalence of antiphospholipid antibodies. J Thromb Haemost JTH. 2011;9(7):1350\u20134.","journal-title":"J Thromb Haemost JTH"},{"issue":"8","key":"568_CR31","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/1076029613486538","volume":"20","author":"R Rajan","year":"2014","unstructured":"Rajan R, Ahluwalia J, Lal V. Prothrombotic states in migraine. Clin Appl Thromb Off J Int Acad Clin Appl Thromb. 2014;20(8):851\u20136.","journal-title":"Clin Appl Thromb Off J Int Acad Clin Appl Thromb"},{"issue":"1","key":"568_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1468-2982.1991.1101019.x","volume":"11","author":"R Hering","year":"1991","unstructured":"Hering R, Couturier EG, Steiner TJ, Asherson RA, Clifford RF. Anticardiolipin antibodies in migraine. Cephalalgia Int J Headache. 1991;11(1):19\u201321.","journal-title":"Cephalalgia Int J Headache"},{"issue":"10","key":"568_CR33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1468-2982.2008.01646.x","volume":"28","author":"FMK Williams","year":"2008","unstructured":"Williams FMK, Cherkas LF, Bertolaccini ML, Murru V, Surdulescu GL, Hughes GRV, et al. Migraine and antiphospholipid antibodies: no association found in migraine-discordant monozygotic twins. Cephalalgia Int J Headache. 2008;28(10):1048\u201352.","journal-title":"Cephalalgia Int J Headache"},{"issue":"5","key":"568_CR34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-0038-1651625","volume":"69","author":"DA Tsakiris","year":"1993","unstructured":"Tsakiris DA, Kappos L, Reber G, Marbet GA, Le Floch-Rohr J, Roux E, et al. Lack of association between antiphospholipid antibodies and migraine. Thromb Haemost. 1993;69(5):415\u20137.","journal-title":"Thromb Haemost"},{"issue":"5","key":"568_CR35","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1212\/WNL.50.5.1433","volume":"50","author":"GE Tietjen","year":"1998","unstructured":"Tietjen GE, Day M, Norris L, Aurora S, Halvorsen A, Schultz LR, et al. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology. 1998;50(5):1433\u201340.","journal-title":"Neurology"},{"issue":"6","key":"568_CR36","first-page":"455","volume":"22","author":"D Intiso","year":"2002","unstructured":"Intiso D, Crociani P, Fogli D, Grandone E, Cappucci G, Di Rienzo F, et al. Occurrence of factor V Leiden mutation (Arg506Gln) and anticardiolipin antibodies in migraine patients. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2002;22(6):455\u20138.","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"issue":"5","key":"568_CR37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/qjmed\/93.5.317","volume":"93","author":"MJ Cuadrado","year":"2000","unstructured":"Cuadrado MJ, Khamashta MA, Hughes GR. Migraine and stroke in young women. QJM Mon J Assoc Physicians. 2000;93(5):317\u20138.","journal-title":"QJM Mon J Assoc Physicians"},{"issue":"5","key":"568_CR38","first-page":"756","volume":"31","author":"L Stojanovich","year":"2013","unstructured":"Stojanovich L, Kontic M, Smiljanic D, Djokovic A, Stamenkovic B, Marisavljevic D. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome. Clin Exp Rheumatol. 2013;31(5):756\u201360.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"568_CR39","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","volume":"74","author":"R Cervera","year":"2015","unstructured":"Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ram\u00f3n E, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2015;74(6):1011\u20138. Provide strong epidemiologic data from the largest prospective cohort of APS patients.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"568_CR40","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.21041","volume":"52","author":"C Franc\u00e8s","year":"2005","unstructured":"Franc\u00e8s C, Niang S, Laffitte E, le Pelletier F, Costedoat N, Piette JC. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum. 2005;52(6):1785\u201393.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"568_CR41","first-page":"499","volume":"23","author":"E Toubi","year":"2005","unstructured":"Toubi E, Krause I, Fraser A, Lev S, Stojanovich L, Rovensky J, et al. Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome. Clin Exp Rheumatol. 2005;23(4):499\u2013504.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"568_CR42","first-page":"1344","volume":"31","author":"Y Shoenfeld","year":"2004","unstructured":"Shoenfeld Y, Lev S, Blatt I, Blank M, Font J, von Landenberg P, et al. Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol. 2004;31(7):1344\u20138.","journal-title":"J Rheumatol"},{"issue":"1","key":"568_CR43","first-page":"134","volume":"16","author":"S Liimatainen","year":"2009","unstructured":"Liimatainen S, Peltola M, Fallah M, Kharazmi E, Haapala A-M, Peltola J. The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures. Eur J Neurol Off J Eur Fed Neurol Soc. 2009;16(1):134\u201341.","journal-title":"Eur J Neurol Off J Eur Fed Neurol Soc"},{"issue":"2","key":"568_CR44","first-page":"160","volume":"18","author":"NN Maalouf","year":"2013","unstructured":"Maalouf NN, Hinduja A, Shihabuddin BS. Primary antiphospholipid syndrome manifesting as partial status epilepticus. Neurosci Riyadh Saudi Arab. 2013;18(2):160\u20132.","journal-title":"Neurosci Riyadh Saudi Arab"},{"issue":"5","key":"568_CR45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jamaneurol.2014.188","volume":"71","author":"M-S Ong","year":"2014","unstructured":"Ong M-S, Kohane IS, Cai T, Gorman MP, Mandl KD. Population-level evidence for an autoimmune etiology of epilepsy. JAMA Neurol. 2014;71(5):569\u201374. First study to properly assess the link between APS diagnosis and epilepsy in a large study-population cohort.","journal-title":"JAMA Neurol"},{"issue":"1","key":"568_CR46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00005792-200001000-00006","volume":"79","author":"MJ Cuadrado","year":"2000","unstructured":"Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GR. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore). 2000;79(1):57\u201368.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"568_CR47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neurol.2011.01.021","volume":"168","author":"N Ahbeddou","year":"2012","unstructured":"Ahbeddou N, Ait Ben Haddou E, Hammi S, Slimani C, Regragui W, Benomar A, et al. Multiple sclerosis associated with antiphospholipid syndrome: diagnostic and therapeutic difficulties. Rev Neurol (Paris). 2012;168(1):65\u20139.","journal-title":"Rev Neurol (Paris)"},{"issue":"2","key":"568_CR48","first-page":"85","volume":"13","author":"I Lima","year":"2007","unstructured":"Lima I, Melo A, Brandi IV, Costa O, Santiago M. Lupoid sclerosis: what is the role of antiphospholipid antibodies? J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2007;13(2):85\u20136.","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"568_CR49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/1752-1947-2-348","volume":"2","author":"MA Komolafe","year":"2008","unstructured":"Komolafe MA, Komolafe EO, Sunmonu TA, Olateju SO, Asaleye CM, Adesina OA, et al. New onset neuromyelitis optica in a young Nigerian woman with possible antiphospholipid syndrome: a case report. J Med Case Reports. 2008;2:348.","journal-title":"J Med Case Reports"},{"issue":"7","key":"568_CR50","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejim.2006.02.018","volume":"17","author":"FJ Fern\u00e1ndez-Fern\u00e1ndez","year":"2006","unstructured":"Fern\u00e1ndez-Fern\u00e1ndez FJ, Rivera-Gallego A, de la Fuente-Aguado J, P\u00e9rez-Fern\u00e1ndez S, Mu\u00f1oz-Fern\u00e1ndez D. Antiphospholipid syndrome mimicking multiple sclerosis in two patients. Eur J Intern Med. 2006;17(7):500\u20132.","journal-title":"Eur J Intern Med"},{"issue":"10","key":"568_CR51","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/jnnp.2007.117713","volume":"78","author":"M Liedorp","year":"2007","unstructured":"Liedorp M, Sanchez E, van Hoogstraten IMW, von Blomberg BME, Barkhof F, Polman CH, et al. No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up. J Neurol Neurosurg Psychiatry. 2007;78(10):1146\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"568_CR52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2377-7-36","volume":"7","author":"CJ Bidot","year":"2007","unstructured":"Bidot CJ, Horstman LL, Jy W, Jimenez JJ, Bidot C, Ahn YS, et al. Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol. 2007;7:36.","journal-title":"BMC Neurol"},{"issue":"4","key":"568_CR53","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1191\/1352458505ms1208oa","volume":"11","author":"J Vilisaar","year":"2005","unstructured":"Vilisaar J, Wilson M, Niepel G, Blumhardt LD, Constantinescu CS. A comparative audit of anticardiolipin antibodies in oligoclonal band negative and positive multiple sclerosis. Mult Scler Houndmills Basingstoke Engl. 2005;11(4):378\u201380.","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"issue":"3","key":"568_CR54","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.81","volume":"49","author":"J Sastre-Garriga","year":"2001","unstructured":"Sastre-Garriga J, Reverter JC, Font J, Tintor\u00e9 M, Espinosa G, Montalban X. Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis. Ann Neurol. 2001;49(3):408\u201311.","journal-title":"Ann Neurol"},{"issue":"3","key":"568_CR55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/jaut.2000.0367","volume":"14","author":"V Roussel","year":"2000","unstructured":"Roussel V, Yi F, Jauberteau MO, Couderq C, Lacombe C, Michelet V, et al. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients. J Autoimmun. 2000;14(3):259\u201365.","journal-title":"J Autoimmun"},{"issue":"2","key":"568_CR56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1191\/096120399678847461","volume":"8","author":"JW IJdo","year":"1999","unstructured":"IJdo JW, Conti-Kelly AM, Greco P, Abedi M, Amos M, Provenzale JM, et al. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus. 1999;8(2):109\u201315.","journal-title":"Lupus"},{"issue":"9","key":"568_CR57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0248-8663(99)80042-3","volume":"19","author":"MA Cordoliani","year":"1998","unstructured":"Cordoliani MA, Michon-Pasturel U, Rerat K, Arvieux J, Masy E, Hachulla E, et al. Multiple sclerosis and antiphospholipid antibodies: study of 62 consecutive patients. Rev M\u00e9decine Interne Fond\u00e9e Par Soci\u00e9t\u00e9 Natl Francaise M\u00e9decine Interne. 1998;19(9):635\u20139.","journal-title":"Rev M\u00e9decine Interne Fond\u00e9e Par Soci\u00e9t\u00e9 Natl Francaise M\u00e9decine Interne"},{"issue":"3","key":"568_CR58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1620\/tjem.178.203","volume":"178","author":"Y Sugiyama","year":"1996","unstructured":"Sugiyama Y, Yamamoto T. Characterization of serum anti-phospholipid antibodies in patients with multiple sclerosis. Tohoku J Exp Med. 1996;178(3):203\u201315.","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"568_CR59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-0404.1993.tb04214.x","volume":"88","author":"T Fukazawa","year":"1993","unstructured":"Fukazawa T, Moriwaka F, Mukai M, Hamada T, Koike T, Tashiro K. Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand. 1993;88(3):184\u20139.","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"568_CR60","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.410440408","volume":"44","author":"D Karussis","year":"1998","unstructured":"Karussis D, Leker RR, Ashkenazi A, Abramsky O. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol. 1998;44(4):629\u201334.","journal-title":"Ann Neurol"},{"issue":"4","key":"568_CR61","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archneur.55.4.517","volume":"55","author":"A Tourbah","year":"1998","unstructured":"Tourbah A, Clapin A, Gout O, Fontaine B, Liblau R, Batteux F, et al. Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study. Arch Neurol. 1998;55(4):517\u201321.","journal-title":"Arch Neurol"},{"issue":"5","key":"568_CR62","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jnnp.72.5.647","volume":"72","author":"O Heinzlef","year":"2002","unstructured":"Heinzlef O, Weill B, Johanet C, Sazdovitch V, Caillat-Zucman S, Tournier-Lasserve E, et al. Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. J Neurol Neurosurg Psychiatry. 2002;72(5):647\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"568_CR63","first-page":"172","volume":"12","author":"M Etemadifar","year":"2013","unstructured":"Etemadifar M, Dehghani L, Tahani S, Toghianifar N, Rahaimi M, Eskandari N. Neurological manifestations in patients with antiphospholipid syndrome. Iran J Neurol. 2013;12(4):172\u20135.","journal-title":"Iran J Neurol"},{"issue":"2","key":"568_CR64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","volume":"72","author":"R Cervera","year":"1993","unstructured":"Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 1993;72(2):113\u201324.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"568_CR65","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3899\/jrheum.080268","volume":"35","author":"NM Orzechowski","year":"2008","unstructured":"Orzechowski NM, Wolanskyj AP, Ahlskog JE, Kumar N, Moder KG. Antiphospholipid antibody-associated chorea. J Rheumatol. 2008;35(11):2165\u201370.","journal-title":"J Rheumatol"},{"issue":"13","key":"568_CR66","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/mds.23863","volume":"26","author":"P Reiner","year":"2011","unstructured":"Reiner P, Galanaud D, Leroux G, Vidailhet M, Haroche J, Huong DLT, et al. Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies. Mov Disord Off J Mov Disord Soc. 2011;26(13):2422\u20137.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"1\u20132","key":"568_CR67","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jns.2007.10.003","volume":"267","author":"Y-C Huang","year":"2008","unstructured":"Huang Y-C, Lyu R-K, Chen S-T, Chu Y-C, Wu Y-R. Parkinsonism in a patient with antiphospholipid syndrome\u2014case report and literature review. J Neurol Sci. 2008;267(1\u20132):166\u20139.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"568_CR68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2009.03.011","volume":"281","author":"M Carecchio","year":"2009","unstructured":"Carecchio M, Comi C, Varrasi C, Stecco A, Sainaghi PP, Bhatia K, et al. Complex movement disorders in primary antiphospholipid syndrome: a case report. J Neurol Sci. 2009;281(1\u20132):101\u20133.","journal-title":"J Neurol Sci"},{"issue":"6","key":"568_CR69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000354614","volume":"21","author":"W-H Chen","year":"2014","unstructured":"Chen W-H, Chen C-H, Chui C, Lui C-C, Chen C-J, Yin H-L. Antiphospholipid antibodies and cerebellar ataxia: a clinical analysis and literature review. Neuroimmunomodulation. 2014;21(6):283\u201390. Interesting recent review, up to date on cerebellar ataxia in aPL and APS patients.","journal-title":"Neuroimmunomodulation"},{"issue":"7","key":"568_CR70","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.braindev.2009.07.009","volume":"32","author":"N Ishikawa","year":"2010","unstructured":"Ishikawa N, Kobayashi M. Recurrent acute cerebellar ataxia associated with anti-cardiolipin antibodies. Brain Dev. 2010;32(7):588\u201391.","journal-title":"Brain Dev"},{"issue":"1\u20132","key":"568_CR71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jneuroim.2007.08.002","volume":"190","author":"DK Sokol","year":"2007","unstructured":"Sokol DK, O\u2019Brien RS, Wagenknecht DR, Rao T, McIntyre JA. Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis. J Neuroimmunol. 2007;190(1\u20132):151\u20136.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"568_CR72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4088\/JCP.v59n0105","volume":"59","author":"M Schwartz","year":"1998","unstructured":"Schwartz M, Rochas M, Weller B, Sheinkman A, Tal I, Golan D, et al. High association of anticardiolipin antibodies with psychosis. J Clin Psychiatry. 1998;59(1):20\u20133.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"568_CR73","first-page":"32","volume":"37","author":"M Schwartz","year":"2000","unstructured":"Schwartz M, Silver H. Lymphocytes, autoantibodies and psychosis\u2014coincidence versus etiological factor: an update. Isr J Psychiatry Relat Sci. 2000;37(1):32\u20136.","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"2","key":"568_CR74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2006.07.006","volume":"27","author":"RD Strous","year":"2006","unstructured":"Strous RD, Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun. 2006;27(2):71\u201380.","journal-title":"J Autoimmun"},{"issue":"7","key":"568_CR75","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0006-3223(91)90019-I","volume":"30","author":"KN Chengappa","year":"1991","unstructured":"Chengappa KN, Carpenter AB, Keshavan MS, Yang ZW, Kelly RH, Rabin BS, et al. Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients. Biol Psychiatry. 1991;30(7):731\u20135.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"568_CR76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0447.1993.tb03349.x","volume":"87","author":"M Maes","year":"1993","unstructured":"Maes M, Meltzer H, Jacobs J, Suy E, Calabrese J, Minner B, et al. Autoimmunity in depression: increased antiphospholipid autoantibodies. Acta Psychiatr Scand. 1993;87(3):160\u20136.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"568_CR77","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1176\/appi.psy.49.5.438","volume":"49","author":"H Raza","year":"2008","unstructured":"Raza H, Epstein SA, Pao M, Rosenstein DL. Mania: psychiatric manifestations of the antiphospholipid syndrome. Psychosomatics. 2008;49(5):438\u201341.","journal-title":"Psychosomatics"},{"issue":"10","key":"568_CR78","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/0961203310397564","volume":"20","author":"S Barros","year":"2011","unstructured":"Barros S, de Carvalho J. Pathological gambling and primary antiphospholipid (Hughes) syndrome: a unique neuropsychiatric association. Lupus. 2011;20(10):1086\u20139.","journal-title":"Lupus"},{"issue":"1","key":"568_CR79","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/0891988712436691","volume":"25","author":"JN Avari","year":"2012","unstructured":"Avari JN, Young RC. A patient with bipolar disorder and antiphospholipid syndrome. J Geriatr Psychiatry Neurol. 2012;25(1):26\u20138.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"11","key":"568_CR80","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1191\/0961203302lu255oa","volume":"11","author":"S Shrot","year":"2002","unstructured":"Shrot S, Katzav A, Korczyn AD, Litvinju Y, Hershenson R, Pick CG, et al. Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus. 2002;11(11):736\u201343.","journal-title":"Lupus"},{"issue":"2\u20133","key":"568_CR81","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s12016-009-8154-x","volume":"38","author":"A Katzav","year":"2010","unstructured":"Katzav A, Shoenfeld Y, Chapman J. The pathogenesis of neural injury in animal models of the antiphospholipid syndrome. Clin Rev Allergy Immunol. 2010;38(2\u20133):196\u2013200.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"568_CR82","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11926-011-0224-4","volume":"14","author":"S Appenzeller","year":"2012","unstructured":"Appenzeller S, Lapa AT, de Carvalho JF, Peres FA, Shoenfeld Y. Cognitive dysfunction and antiphospholipid antibodies. Curr Rheumatol Rep. 2012;14(1):95\u20138.","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"568_CR83","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1191\/096120301678416060","volume":"10","author":"A Katzav","year":"2001","unstructured":"Katzav A, Pick CG, Korczyn AD, Oest E, Blank M, Shoenfeld Y, et al. Hyperactivity in a mouse model of the antiphospholipid syndrome. Lupus. 2001;10(7):496\u20139.","journal-title":"Lupus"},{"issue":"5","key":"568_CR84","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/nan.12180","volume":"41","author":"K Frauenknecht","year":"2015","unstructured":"Frauenknecht K, Katzav A, Weiss Lavi R, Sabag A, Otten S, Chapman J, et al. Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurones. Neuropathol Appl Neurobiol. 2015;41(5):657\u201371. Interesting and recent bench paper, which provide structural basis for the behavioral and cognitive abnormalities of APS mice model.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1\u20132","key":"568_CR85","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2014.04.003","volume":"272","author":"A Katzav","year":"2014","unstructured":"Katzav A, Ben-Ziv T, Blank M, Pick CG, Shoenfeld Y, Chapman J. Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice. J Neuroimmunol. 2014;272(1\u20132):10\u20135.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"568_CR86","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI119572","volume":"100","author":"L Ziporen","year":"1997","unstructured":"Ziporen L, Shoenfeld Y, Levy Y, Korczyn AD. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest. 1997;100(3):613\u20139.","journal-title":"J Clin Invest"},{"issue":"4","key":"568_CR87","first-page":"269","volume":"37","author":"P Nowacki","year":"1999","unstructured":"Nowacki P, Ronin-Walknowska E, Ossowicka-Stepi\u0144ska J. Neuropathological changes within the brain of rabbits with experimental model of antiphospholipid syndrome in different time after immunization. Folia Neuropathol Assoc Pol Neuropathol Med Res Cent Pol Acad Sci. 1999;37(4):269\u201372.","journal-title":"Folia Neuropathol Assoc Pol Neuropathol Med Res Cent Pol Acad Sci"},{"issue":"2","key":"568_CR88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1191\/096120399678847524","volume":"8","author":"J Chapman","year":"1999","unstructured":"Chapman J, Cohen-Armon M, Shoenfeld Y, Korczyn AD. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus. 1999;8(2):127\u201333.","journal-title":"Lupus"},{"issue":"3","key":"568_CR89","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/17402520500217844","volume":"12","author":"J Chapman","year":"2005","unstructured":"Chapman J, Soloveichick L, Shavit S, Shoenfeld Y, Korczyn AD. Antiphospholipid antibodies bind ATP: a putative mechanism for the pathogenesis of neuronal dysfunction. Clin Dev Immunol. 2005;12(3):175\u201380.","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"568_CR90","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1191\/0961203306lu2272rr","volume":"15","author":"R Cimaz","year":"2006","unstructured":"Cimaz R, Meroni PL, Shoenfeld Y. Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome). Lupus. 2006;15(4):191\u20137.","journal-title":"Lupus"},{"issue":"15","key":"568_CR91","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0024-3205(94)00422-6","volume":"54","author":"HH Liou","year":"1994","unstructured":"Liou HH, Wang CR, Chou HC, Arvanov VL, Chen RC, Chang YC, et al. Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor-mediated chloride current in snail neurons. Life Sci. 1994;54(15):1119\u201325.","journal-title":"Life Sci"},{"issue":"5","key":"568_CR92","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s10067-005-0051-y","volume":"25","author":"D Carter","year":"2006","unstructured":"Carter D, Olchovsky D, Yonath H, Langevitz P, Ezra D. Simultaneous deep vein thrombosis and transverse myelitis with negative serology as a first sign of antiphospholipid syndrome: a case report and review of the literature. Clin Rheumatol. 2006;25(5):756\u20138.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"568_CR93","first-page":"93","volume":"18","author":"D Erkan","year":"2011","unstructured":"Erkan D, Kozora E, Lockshin MD. Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome. Pathophysiol Off J Int Soc Pathophysiol ISP. 2011;18(1):93\u2013102.","journal-title":"Pathophysiol Off J Int Soc Pathophysiol ISP"},{"issue":"1\u20132","key":"568_CR94","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jns.2014.08.010","volume":"346","author":"D-S Zhu","year":"2014","unstructured":"Zhu D-S, Fu J, Zhang Y, Li S-X, Zhang G-X, Guan Y-T, et al. Neurological antiphospholipid syndrome: clinical, neuroimaging, and pathological characteristics. J Neurol Sci. 2014;346(1\u20132):138\u201344. Good recent review on neurologic imaging in APS.","journal-title":"J Neurol Sci"},{"issue":"3","key":"568_CR95","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/art.20957","volume":"52","author":"CE Lampropoulos","year":"2005","unstructured":"Lampropoulos CE, Koutroumanidis M, Reynolds PPM, Manidakis I, Hughes GRV, D\u2019Cruz DP. Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus. Arthritis Rheum. 2005;52(3):841\u20136.","journal-title":"Arthritis Rheum"},{"key":"568_CR96","doi-asserted-by":"crossref","unstructured":"Pereira FR, Macri F, Jackowski MP, Kostis WJ, Gris J-C, Beregi J-P, et al. Diffusion tensor imaging in patients with obstetric antiphospholipid syndrome without neuropsychiatric symptoms. Eur Radiol. 2015.","DOI":"10.1007\/s00330-015-3922-x"},{"issue":"6","key":"568_CR97","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1191\/096120301678646119","volume":"10","author":"MJ Cuadrado","year":"2001","unstructured":"Cuadrado MJ, Khamashta MA, Hughes GR. Sticky blood and headache. Lupus. 2001;10(6):392\u20133.","journal-title":"Lupus"},{"issue":"3","key":"568_CR98","first-page":"173","volume":"13","author":"RA Asherson","year":"2007","unstructured":"Asherson RA, Giampaulo D, Singh S, Sulman L. Dramatic response of severe headaches to anticoagulation in a patient with antiphospholipid syndrome. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2007;13(3):173\u20134.","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"3","key":"568_CR99","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/PSY.0b013e31828acfbc","volume":"75","author":"EV Roie","year":"2013","unstructured":"Roie EV, Labarque V, Renard M, Van Geet C, Gabri\u00ebls L. Obsessive-compulsive behavior as presenting symptom of primary antiphospholipid syndrome. Psychosom Med. 2013;75(3):326\u201330.","journal-title":"Psychosom Med"},{"issue":"5","key":"568_CR100","first-page":"579.e1\u20133","volume":"34","author":"J-Y Lai","year":"2012","unstructured":"Lai J-Y, Wu P-C, Chen H-C, Lee M-B. Early neuropsychiatric involvement in antiphospholipid syndrome. Gen Hosp Psychiatry. 2012;34(5):579.e1\u20133.","journal-title":"Gen Hosp Psychiatry"},{"key":"568_CR101","first-page":"471543","volume":"2012","author":"Y Ayalew","year":"2012","unstructured":"Ayalew Y, Khattak F. Antiphospholipid antibody syndrome presenting with hemichorea. Case Rep Rheumatol. 2012;2012:471543.","journal-title":"Case Rep Rheumatol"},{"key":"568_CR102","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5334\/tohm.250","volume":"5","author":"D Safarpour","year":"2015","unstructured":"Safarpour D, Buckingham S, Jabbari B. Chorea associated with high titers of antiphospholipid antibodies in the absence of antiphospholipid antibody syndrome. Tremor Hyperkinetic Mov N Y N. 2015;5:294.","journal-title":"Tremor Hyperkinetic Mov N Y N"},{"issue":"5","key":"568_CR103","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1179\/acb.2010.075","volume":"65","author":"J Demonty","year":"2010","unstructured":"Demonty J, Gonce M, Ribai P, Verellen-Dumoulin C, Hustinx R. Chorea associated with anti-phospholipid antibodies: case report. Acta Clin Belg. 2010;65(5):350\u20133.","journal-title":"Acta Clin Belg"},{"issue":"14","key":"568_CR104","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1177\/0961203314551084","volume":"23","author":"C Brogna","year":"2014","unstructured":"Brogna C, Mariotti P, Manna R. Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea. Lupus. 2014;23(14):1449\u201351.","journal-title":"Lupus"},{"issue":"6","key":"568_CR105","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/annrheumdis-2013-203622","volume":"73","author":"D Erkan","year":"2014","unstructured":"Erkan D, Willis R, Murthy VL, Basra G, Vega J, Ruiz-Lim\u00f3n P, et al. A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients. Ann Rheum Dis. 2014;73(6):1176\u201380. Only therapeutic trial to evaluate the benefit of an immunosuppressive drug in non-criteria APS manifestations.","journal-title":"Ann Rheum Dis"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-016-0568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-016-0568-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-016-0568-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T01:52:05Z","timestamp":1600221125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-016-0568-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1007\/s11926-016-0568-x","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2]]},"article-number":"11"}}